Found 10 articles for: "cysteamine"
Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action
February 2024 | Volume 23 | Issue 2 | Original Article | 9 | Copyright © February 2024
Background: Modified Kligman's formula (mKF) is the gold standard treatment for melasma; however, its prolonged use is not recommended due to side effects. Cysteamine is a potent...
Read MoreComparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness
January 2024 | Volume 23 | Issue 1 | Original Article | 1260 | Copyright © January 2024
Dyschromia is the result of irregular facial pigmentation. These cutaneous manifestations can have a significant impact on the quality of life of those affected, especially among females and skin...
Read MoreTopical Treatments for Melasma and Post-inflammatory Hyperpigmentation
November 2023 | Volume 22 | Issue 11 | Original Article | 1118 | Copyright © November 2023
Background: Dyschromia is one of the most common reasons for patients to seek dermatological care, especially among individuals with skin of color. Most cases present as melasma ...
Read MoreWATCH VIDEO ABSTRACT: Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols
March 2023 | Volume 22 | Issue 3 | Original Article | 288 | Copyright © March 2023
Read MoreScarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols
July 2023 | Volume 22 | Issue 7 | Original Article | 7253 | Copyright © July 2023
Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesi...
Read MoreTopical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines
December 2021 | Volume 20 | Issue 12 | Original Article | 1276 | Copyright © December 2021
Cysteamine is an aminothiol naturally present in cells of the human body as an antioxidant resulting from the degradation of Coenzyme A. Physiologically it is well distributed in mammalian tissues. Hi...
Read MoreThe Therapeutic Use of Antioxidants for Melasma
August 2020 | Volume 19 | Issue 8 | Original Article | 788 | Copyright © August 2020
Melasma is a chronic dermatologic condition with an incompletely understood pathogenesis and well-demonstrated impact on patient quality of life. Melasma is a common cause for seeking dermatologic car...
Read MoreMelasma’s Impact on Quality of Life
February 2020 | Volume 19 | Issue 2 | Original Article | 184 | Copyright © February 2020
Melasma is a commonly acquired condition that mostly affects women with Fitzpatrick skin types III-VI with prominent brown pigmentation with or without an underlying erythema. Despite multiple treatme...
Read MoreTopical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials
November 2019 | Volume 18 | Issue 11 | Original Article | 1156 | Copyright © November 2019
Background: Melasma is an acquired skin disease characterized by symmetric hyperpigmentatio...
Read MoreCME: Therapeutic Insights in Melasma and Hyperpigmentation Management
August 2019 | Volume 18 | Issue 8 | Original Article | 718 | Copyright © August 2019
Melasma and postinflammatory hyperpigmentation (PIH) are the most common forms of dyschromia in patients with skin of color. Both are associated with a high psychological burden of disease. To exacerb...
Read MoreMedia and other results for: "cysteamine"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
